Risk of Type 2 Diabetes Mellitus
The Special Issue “Risk of Type 2 Diabetes Mellitus: Cardiorenometabolic Syndrome and Its Components”, guest-edited by Dr. Andrej Belančić, Prof. Bojan Jelaković, and Dr. Martina Matovinović, explored the complex interrelationship between metabolic syndrome (MetS) and the global burden of type 2 dia...
Guardado en:
| Formato: | Online |
|---|---|
| Lenguaje: | inglés |
| Publicado: |
MDPI - Multidisciplinary Digital Publishing Institute
2025
|
| Materias: | |
| Acceso en línea: | ONIX_20250812T110751_9783725847136_594 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1869526097599660032 |
|---|---|
| collection | Directory of Open Access Books |
| description | The Special Issue “Risk of Type 2 Diabetes Mellitus: Cardiorenometabolic Syndrome and Its Components”, guest-edited by Dr. Andrej Belančić, Prof. Bojan Jelaković, and Dr. Martina Matovinović, explored the complex interrelationship between metabolic syndrome (MetS) and the global burden of type 2 diabetes mellitus (T2DM). This interdisciplinary collection examined how insulin resistance, dyslipidemia, central obesity, and hypertension—core components of MetS—converge to elevate the risk of T2DM and cardiovascular disease, the leading causes of morbidity and mortality worldwide. Published in Diabetology (ISSN 2673-4540), this Special Issue brought together high-quality original research articles, reviews, and communications addressing the biochemical, molecular, physiological, and clinical aspects of cardiorenometabolic syndrome. Topics included genetic susceptibility, pharmacogenetics, lifestyle interventions, diagnostic biomarkers, and emerging drug therapies, offering a comprehensive understanding of the mechanisms underlying metabolic-driven diabetes. Now compiled as a Reprint, this volume serves as a timely, authoritative resource for clinicians, researchers, and public health professionals. By synthesizing current knowledge and showcasing multidisciplinary insights, it aims to advance both clinical practice and scientific inquiry into T2DM prevention, early detection, and treatment. This Reprint stands as a valuable contribution to the ongoing efforts to mitigate the global impact of type 2 diabetes and its associated complications. |
| format | Online |
| id | doab-20.500.12854ir-165839 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2025 |
| publishDateRange | 2025 |
| publishDateSort | 2025 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1658392025-08-12T10:21:47Z Risk of Type 2 Diabetes Mellitus Belančić, Andrej Jelaković, Bojan Matovinović, Martina type 2 diabetes mellitus protein O-GlcNAcylation glutamine fructose-6P amidotransferase O-GlcNAc transferase O-GlcNAcase metabolic syndrome pharmacological interventions research cardiovascular risk ADVANCE risk score calculator elderly diabetes mellitus obesity eating patterns binge eating emotional eating pharmacogenetics pharmacokinetics drug–drug–transporter gene interactions drug–drug-gene interactions lipid-lowering agents antihypertensives antihyperglycemics clinical decision making type 2 glycated hemoglobin patient-centered care pharmacists population health quality indicators type 2 diabetes exosomes microRNA biomarkers therapy insulin resistance genetic susceptibility genome-wide association study cardiovascular outcomes aerobic exercise resistance training combined training heart rate variability inflammatory markers n/a thema EDItEUR::M Medicine and Nursing The Special Issue “Risk of Type 2 Diabetes Mellitus: Cardiorenometabolic Syndrome and Its Components”, guest-edited by Dr. Andrej Belančić, Prof. Bojan Jelaković, and Dr. Martina Matovinović, explored the complex interrelationship between metabolic syndrome (MetS) and the global burden of type 2 diabetes mellitus (T2DM). This interdisciplinary collection examined how insulin resistance, dyslipidemia, central obesity, and hypertension—core components of MetS—converge to elevate the risk of T2DM and cardiovascular disease, the leading causes of morbidity and mortality worldwide. Published in Diabetology (ISSN 2673-4540), this Special Issue brought together high-quality original research articles, reviews, and communications addressing the biochemical, molecular, physiological, and clinical aspects of cardiorenometabolic syndrome. Topics included genetic susceptibility, pharmacogenetics, lifestyle interventions, diagnostic biomarkers, and emerging drug therapies, offering a comprehensive understanding of the mechanisms underlying metabolic-driven diabetes. Now compiled as a Reprint, this volume serves as a timely, authoritative resource for clinicians, researchers, and public health professionals. By synthesizing current knowledge and showcasing multidisciplinary insights, it aims to advance both clinical practice and scientific inquiry into T2DM prevention, early detection, and treatment. This Reprint stands as a valuable contribution to the ongoing efforts to mitigate the global impact of type 2 diabetes and its associated complications. 2025-08-12T10:21:44Z 2025-08-12T10:21:44Z 2025 book ONIX_20250812T110751_9783725847136_594 9783725847136 9783725847143 https://directory.doabooks.org/handle/20.500.12854/165839 eng image/jpeg Attribution 4.0 International https://mdpi.com/books https://mdpi.com/books/pdfview/book/11259 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-7258-4714-3 10.3390/books978-3-7258-4714-3 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783725847136 9783725847143 158 open access |
| spellingShingle | type 2 diabetes mellitus protein O-GlcNAcylation glutamine fructose-6P amidotransferase O-GlcNAc transferase O-GlcNAcase metabolic syndrome pharmacological interventions research cardiovascular risk ADVANCE risk score calculator elderly diabetes mellitus obesity eating patterns binge eating emotional eating pharmacogenetics pharmacokinetics drug–drug–transporter gene interactions drug–drug-gene interactions lipid-lowering agents antihypertensives antihyperglycemics clinical decision making type 2 glycated hemoglobin patient-centered care pharmacists population health quality indicators type 2 diabetes exosomes microRNA biomarkers therapy insulin resistance genetic susceptibility genome-wide association study cardiovascular outcomes aerobic exercise resistance training combined training heart rate variability inflammatory markers n/a thema EDItEUR::M Medicine and Nursing Risk of Type 2 Diabetes Mellitus |
| title | Risk of Type 2 Diabetes Mellitus |
| title_full | Risk of Type 2 Diabetes Mellitus |
| title_fullStr | Risk of Type 2 Diabetes Mellitus |
| title_full_unstemmed | Risk of Type 2 Diabetes Mellitus |
| title_short | Risk of Type 2 Diabetes Mellitus |
| title_sort | risk of type 2 diabetes mellitus |
| topic | type 2 diabetes mellitus protein O-GlcNAcylation glutamine fructose-6P amidotransferase O-GlcNAc transferase O-GlcNAcase metabolic syndrome pharmacological interventions research cardiovascular risk ADVANCE risk score calculator elderly diabetes mellitus obesity eating patterns binge eating emotional eating pharmacogenetics pharmacokinetics drug–drug–transporter gene interactions drug–drug-gene interactions lipid-lowering agents antihypertensives antihyperglycemics clinical decision making type 2 glycated hemoglobin patient-centered care pharmacists population health quality indicators type 2 diabetes exosomes microRNA biomarkers therapy insulin resistance genetic susceptibility genome-wide association study cardiovascular outcomes aerobic exercise resistance training combined training heart rate variability inflammatory markers n/a thema EDItEUR::M Medicine and Nursing |
| topic_facet | type 2 diabetes mellitus protein O-GlcNAcylation glutamine fructose-6P amidotransferase O-GlcNAc transferase O-GlcNAcase metabolic syndrome pharmacological interventions research cardiovascular risk ADVANCE risk score calculator elderly diabetes mellitus obesity eating patterns binge eating emotional eating pharmacogenetics pharmacokinetics drug–drug–transporter gene interactions drug–drug-gene interactions lipid-lowering agents antihypertensives antihyperglycemics clinical decision making type 2 glycated hemoglobin patient-centered care pharmacists population health quality indicators type 2 diabetes exosomes microRNA biomarkers therapy insulin resistance genetic susceptibility genome-wide association study cardiovascular outcomes aerobic exercise resistance training combined training heart rate variability inflammatory markers n/a thema EDItEUR::M Medicine and Nursing |
| url | ONIX_20250812T110751_9783725847136_594 |